Healthscore 354·4 metrosupdated 2h ago
Insurance Denials for Brand-Name Drugs Surge by 67% in Recent Study
A new study reveals a significant increase in insurance denials for brand-name drugs without generic alternatives, rising 67% from 2018 to 2024. The findings highlight the impact of insurance policies on patient access to medications, particularly GLP-1 weight-loss drugs, which faced the highest denial rates.
Where it's breaking
Local coverage
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.